GRAIL, Inc. is a healthcare company headquartered in Menlo Park, California, focused on detecting cancer early, when it can be cured. Its flagship product, the Galleri multi-cancer early detection (MCED) test, uses a single blood draw and methylation-based genomic sequencing to screen for a signal shared across more than 50 types of cancer, many… - View it on GitHub